New 15-PGDH inhibitors detailed in Scinnohub Pharmaceutical patent

Feb. 19, 2024

Work at Scinnohub Pharmaceutical Co. Ltd. has led to the identification of new 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitors.

BioWorld Science Ear, nose and throat Patents

Today's news in brief

BioWorld

BioWorld briefs for Sept. 18, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Sept. 18, 2025.

Health professional pointing stethoscope at Clinical Trial words, icons

‘Prolific’ Regeneron won’t stop with phase III FOP data drop

BioWorld

“People have some inability to focus on [Regeneron Pharmaceuticals Inc.’s] pipeline,” which stands as “the most prolific in the industry, I would dare to say,”...

The ‘molecular revolution’ driving R&D of new cancer therapeutics

BioWorld Asia

“New explosions in biotechnology are allowing us to interrogate cancers at a very sophisticated level compared to before,” Dennis Slamon told audience members at...

Elderly woman holding illustration of brain with missing puzzle piece

Remynd’s REM-127 yields positive phase II data in Alzheimer’s

BioWorld

Remynd NV has turned in positive phase IIa data for a new target in Alzheimer’s disease, showing that restoring calcium homeostasis in neurons reduces levels of...